Cytel Partners with Nested Knowledge to Power the Next Generation of AI-Enhanced LiveSLR® for HEOR and HTACambridge, MA and St. Paul, MN, May 09, 2025 (GLOBE NEWSWIRE) -- Cytel, a global leader in evidence generation and data-driven decision-making, today announced a partnership with Nested Knowledge, a pioneer in AI-powered systematic literature review technology. The partnership pairs Cytel’s proprietary LiveSLR® software with Nested Knowledge’s advanced AI platform, creating an advanced, fully auditable living evidence platform available for Health Economics and Outcomes Research (HEOR) and Health Technology Assessment (HTA).
Cytel Launches East Horizon™ Platform: Advancing the Science of Adaptive Clinical Trial Design and SimulationNew platform integrates East® software’s established adaptive design workflows with cutting-edge cloud computing simulation and advanced design capabilities for enhanced clinical development.
Cytel and GSK Partner to Advance Clinical Trial Design with SolaraGSK plans expansion of Solara clinical trial strategy platform to optimize design selection across therapeutic areas
Recent Fluvoxamine COVID benefits discovered using Cytel-designed platform trial
The recently announced benefits of fluvoxamine, an inexpensive drug currently approved as an antidepressant, for treating COVID-19, were confirmed thanks to a platform research study, the TOGETHER Trial, which included key design and implementation contributions from Cytel researchers. According to research study data, Fluvoxamine was found to reduce the number of COVID-19 patients ending up in hospital by approximately 30 percent.
